AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 14, 2026, 12:02ANA Testing as Routine Diagnostic Work-Up of Women Experiencing REPL – RBMO
-
Apr 13, 2026, 08:40Antonio La Marca: April 15 Webinar to Focus on Thermal Ablation for Fibroids and Adenomyosis
-
Apr 13, 2026, 08:34Raising Awareness of Endometriosis at Paris Women’s Health Forum 2026 – Filière Endométriose Île-de-France
-
Apr 12, 2026, 07:31Antonio La Marca: Upcoming Webinar to Explore Uterine Artery Embolization and Thermal Ablation of Fibroids
-
Apr 12, 2026, 07:28South Carolina, IVF is Under Threat Again! – RESOLVE
-
Apr 12, 2026, 07:18New Series Explores Paths Into Reproductive Medicine Leadership – ASRM
-
Apr 12, 2026, 07:11Latest Episode of RCOG Surgical Skills Project – RCOG
-
Apr 12, 2026, 07:03Christopher Robinson: Uterine Artery Injury During Cesarean Deliveries
-
Apr 12, 2026, 06:58Robert Brown: Overview of Maternal Mortality